Pentobarbital sodium inhibits the release of noradrenaline in the medial preoptic area in the rat.
The effect of pentobarbital sodium (PB) on noradrenaline (NA) release in the medial preoptic area was studied in ovariectomized rats by a microdialysis method coupled to HPLC. Dialyzates were collected at 6-min intervals before and after the injection in freely moving rats. PB injected i.p. at a dose of 35 mg/kg caused a marked, approximately 40-50% decrease in NA release, which became evident 50 min after the injection and lasted for another 60 min during which the observation was performed. The results suggest that the anesthetic effect of barbiturates is related to the reduction in NA release in the brain.
Mizuno
T
T
Department of Physiology, Yokohama City University School of Medicine, Japan.
Ito
E
E
Kimura
F
F
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D005260:Female; D017551:Microdialysis; D009638:Norepinephrine / Q000378:metabolism*; D010052:Ovariectomy; D010424:Pentobarbital / Q000494:pharmacology*; D011301:Preoptic Area / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013238:Stereotaxic Techniques
D010424:Pentobarbital; D009638:Norepinephrine